1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Microalbuminuria: new trials by email Literature Review of Microalbuminuria trials Research Report on Microalbuminuria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors Rimonabant, Placebo - Obesity, Microalbuminuria | Phase 3 | Terminated | Sanofi | 174 | 2007-03-01 | 2010-12-10 |
Diabetes Mellitus, Type 2 (1) · Dyslipidemias (1) · Obesity (1)
Body Weight (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Lipid Metabolism Disorders (1) · Metabolic Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Overweight (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Rimonabant (1)
Sanofi (1)
Spain (1)